英文名稱 Anti-phospho-CBL2(Tyr774)

中文名稱 磷酸化原癌蛋白CBL2抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg

抗體來源 Rabbit

交叉反應(yīng) Human, Mouse, Rat, Chicken, Pig, Rabbit, Sheep

產(chǎn)品類型 一抗 磷酸化抗體

研究領(lǐng)域 腫瘤 細(xì)胞生物 免疫學(xué) 信號轉(zhuǎn)導(dǎo)

蛋白分子量 predicted molecular weight: 100kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated Synthesised phosphopeptide derivedfrom human CBL2 around the phosphorylation site of Tyr774

亞 型 IgG

純化方法 affinity purified by Protein A

儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件  Store at -20 °C for one year.

別 名 C CBL; Cas-Br-M (murine) ecotropic retroviraltransforming sequence; Casitas B lineage lymphoma proto oncogene; CBL 2;E3ubiquitin protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; RGD1561386;RING finger protein 55; RNF55v Signal transduction protein CBL; 4732447J05Rik;CBL_HUMAN.